What is Ozempic?
Ozempic is the original semaglutide injection, FDA-approved in 2017 for type 2 diabetes. It lowers blood sugar, reduces cardiovascular risk in diabetics, and — the reason it became a household name — causes significant weight loss as a side effect.
Technically, Ozempic is not approved for weight loss. Wegovy is the same molecule approved for that purpose at a higher dose. But widespread off-label prescribing for weight made "Ozempic" shorthand for the entire GLP-1 category.
If weight management is your goal and you do not have diabetes, most providers will steer you to Wegovy or Zepbound — insurance rarely covers Ozempic off-label.
How it works
Ozempic delivers semaglutide, a GLP-1 receptor agonist that mimics the fullness hormone your gut releases after eating. It boosts insulin when blood sugar is high, suppresses glucagon, slows stomach emptying, and reduces appetite.
For diabetics, the headline benefit is A1C reduction — typically 1.5–2 points — plus proven cardiovascular risk reduction from the SUSTAIN-6 trial. The weight loss (usually 4–6% at diabetes doses) is a secondary effect.
Dosing schedule
Ozempic uses a lower dose range than Wegovy, stepping up every 4 weeks as needed for blood sugar control:
| Dose | When |
|---|---|
| 0.25 mg / week | Weeks 1–4 — starter dose |
| 0.5 mg / week | First maintenance dose |
| 1 mg / week | Step up if more control needed |
| 2 mg / week | Maximum dose |
Results in clinical trials
In the SUSTAIN trial program, Ozempic reduced A1C by 1.5–1.8 points at the 1 mg dose and cut major cardiovascular events by 26% in high-risk patients (SUSTAIN-6). Average weight loss at diabetes doses runs 9–14 lbs — real, but roughly a third of what the higher-dose Wegovy delivers.
Side effects
Common
- Nausea
- Vomiting
- Diarrhea
- Stomach pain
- Constipation
Serious (rare)
- Pancreatitis
- Diabetic retinopathy complications
- Gallbladder problems
- Kidney injury
- Hypoglycemia with insulin or sulfonylureas
How much does Ozempic cost?
Ozempic is usually covered by insurance for diabetes — off-label weight loss use is where costs jump:
| Route | Typical cost |
|---|---|
| List price | ~$950–$1,000 / month |
| With insurance (diabetes diagnosis) | $25–$100 / month copay |
| Novo Nordisk savings card | As low as $25 / month (eligible commercial plans) |
| Off-label for weight loss | Usually full list price — not covered |
Prices vary by clinic, dose, and location — always confirm directly. See real local pricing on our clinic listings.
Frequently asked questions
Can I get Ozempic just for weight loss?
Providers can prescribe it off-label, but insurance almost never covers it without a diabetes diagnosis — leaving you at ~$1,000/month list price. If weight is the goal, Wegovy (same drug, weight-loss approval) or Zepbound usually make more sense for coverage and dosing.
How much weight do people lose on Ozempic?
At diabetes doses (up to 2 mg), trials show 9–14 lbs on average — about 4–6% of body weight. The 15% figures you see in headlines come from Wegovy trials at the higher 2.4 mg dose.
Ozempic vs Wegovy — which should I ask about?
Same molecule. Ozempic = diabetes approval, max 2 mg. Wegovy = weight management approval, max 2.4 mg. If you have type 2 diabetes, Ozempic. If you are treating weight, Wegovy. Read our full Ozempic vs Wegovy comparison for details.
Is there a generic Ozempic?
No FDA-approved generic semaglutide exists yet — patents run into the 2030s. Anything marketed as "generic Ozempic" online is compounded or unregulated product, not an approved generic.
Related medications
This page is for educational purposes only and is not medical advice. Ozempic is a prescription medication — talk to a licensed healthcare provider about whether it is right for you. GLPFinders is a directory service and does not prescribe, sell, or dispense medications.